Improving access to HCV treatment: External jugular venepuncture can overcome problems with difficult venous access

International Journal of Drug Policy

Volumn 18, Issue 5, 2007, Pages 433-436

  Mason, Susan ^a   Watts, Andrew ^a   Sheils, Sinead ^a   Koorey, David ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Antiviral therapy (AVT); Difficult venous access (DVA); External jugular venepuncture (EJV); Hepatitis C (HCV)

Indexed keywords

ANTIVIRAL THERAPY; ARTICLE; BLOOD EXAMINATION; BLOOD SAMPLING; CANNULATION; CLINICAL ARTICLE; CONTRAST RADIOGRAPHY; CONTROLLED STUDY; EXTERNAL JUGULAR VEIN; HEALTH CARE ORGANIZATION; HEALTH CARE POLICY; HEALTH PROGRAM; HEALTH SURVEY; HEPATITIS C; HOSPITAL DEPARTMENT; HUMAN; INCIDENCE; LIVER CELL CARCINOMA; MEDICAL ASSESSMENT; MEDICAL EDUCATION; NURSE CONSULTANT; PATIENT SATISFACTION; PRIORITY JOURNAL; VASCULAR ACCESS; VEIN PUNCTURE;

ADULT; ANTIVIRAL AGENTS; HEPATITIS C, CHRONIC; HUMANS; INJECTIONS, INTRAVENOUS; JUGULAR VEINS; LIVER TRANSPLANTATION; MALE; MEDICAL AUDIT; PATIENT SATISFACTION; PHLEBOTOMY; QUESTIONNAIRES; SUBSTANCE ABUSE, INTRAVENOUS; TREATMENT OUTCOME;

EID: 34548485069     PISSN: 09553959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugpo.2007.01.008     Document Type: Article

References (10)

1. Australia & New Zealand Liver Transplant Registry. (2005). 17th Report (data to December 31, 2005).
2. Australian National Council on AIDS, Hepatitis C and Related Diseases Hepatitis C Sub-Committee. (2006). Hepatitis C Virus Projections Working Group: estimates and projections of the hepatitis C epidemic in Australia 2006. Sydney: National Centre in HIV Epidemiology and Clinical Research (NCHECR).
3. Chen S., and Morgan T. The natural history of hepatitis C virus (HCV) infection. International Journal of Medical Sciences 3 (2006) 47-52
4. Darke S., Ross J., and Kaye S. Physical Injecting sites among injecting drug users in Sydney, Australia. Drug and Alcohol Dependence 62 1 (2001) 77-82
5. Formann E., Steindl-Munda P., Hofer W., et al. Long term followup of chronic hepatitis C patients with sustained virological response to various forms of interferon-based anti-viral therapy. Alimententary Pharmacology &Therapeutics 23 4 (2006) 507-511
6. O'Brien, S., Day, C., Black, E., Thetford, C., & Dolan, K. (2006). Injecting drug users' understanding of hepatitis C. Technical Report 262. Sydney: National Drug and Alcohol Research Centre, University of NSW.
7. Patel K., Muir A.J., and McHutchison J.G. Diagnosis and treatment of chronic hepatitis C infection. British Medical Journal 332 7548 (2006) 1013-1017
8. Russo M., and Fried M. Side effects of therapy for chronic hepatitis C. Gastroenterology 124 (2003) 1711-1719
9. Stafford, J., Degenhardt, L., Black, E., Bruno, R., Buckingham, K., Fetherston, R., et al. (2005). Australian drug trends 2005. Findings from the illicit drug reporting system. National Drug And Alcohol Research Centre Monograph No. 59.
10. Stribling R., Sussman N., and Vierling J.M. Treatment of hepatitis C infection. Gastroenterology Clinics of North America 35 2 (2006) 463-486